ELTX
USDElicio Therapeutics Inc. Common Stock
$9.150-0.120 (-1.294%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$9.270
High
$9.550
Low
$9.070
Volume
0.01M
Company Fundamentals
Market Cap
149.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.11M
Exchange
NCM
Currency
USD
52-Week Range
Low $4.6Current $9.150High $12.62
Related News
GlobeNewswire
Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma
Study will evaluate ELI-002 7P in combination with chemotherapy and a checkpoint inhibitor ("CPI") in the neoadjuvant settingTrial is anticipated to begin enrolling in H1'2026
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.